Structures of dimeric nonstandard nucleotide triphosphate pyrophosphatase from Pyrococcus horikoshii OT3: functional significance of interprotomer conformational changes.

J Mol Biol

Advanced Protein Crystallography Research Group, RIKEN SPring-8 Center, Harima Institute, 1-1-1 Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5148, Japan.

Published: January 2008

Nonstandard nucleotide triphosphate pyrophosphatase (NTPase) can efficiently hydrolyze nonstandard purine nucleotides in the presence of divalent cations. The crystal structures of the NTPase from Pyrococcus horikoshii OT3 (PhNTPase) have been determined in two unliganded forms and in three liganded forms with inosine 5'-monophosphate (IMP), ITP and Mn(2+), which visualize the recognition of these ligands unambiguously. The overall structure of PhNTPase is similar to that of previously reported crystal structures of the NTPase from Methanococcus jannaschii and the human ITPase. They share a similar protomer folding with two domains and a similar homodimeric quaternary structure. The dimeric interface of NTPase is well conserved, and the dimeric state might be important to constitute the active site of this enzyme. A conformational analysis of the five snapshots of PhNTPase structures using the multiple superposition method reveals that IMP, ITP and Mn(2+) bind to the active site without inducing large local conformational changes, indicating that a combination of interdomain and interprotomer rigid-body shifts mainly describes the conformational change of PhNTPase. The interdomain and interprotomer conformations of the ITP liganded form are essentially the same as those observed in the unliganded form 1, indicating that ITP binding to PhNTPase in solution may follow the selection mode in which ITP binds to the subunit that happens to be in the conformation observed in the unliganded form 1. In contrast to the human ITPase inducing a large domain closure upon ITP binding, the interdomain active site cleft is generally closed in PhNTPase and only the IMP binding form shows a remarkable domain opening by 14 degrees only in the B subunit. The interprotomer rigid-body rotation of PhNTPase has a tendency to keep the dimeric 2-fold symmetry, which is also true in human ITPase, thereby suggesting its relevance to the positive cooperativity of the dimeric NTPases. The exception of this rule is observed in the IMP liganded form in which the dimeric 2-fold symmetry is broken by a 3 degrees interprotomer rotation in an unusual direction. A combination of the exceptional interdomain and interprotomer relocations is most likely the reason for the observed asymmetric IMP binding that might be necessary for PhNTPase to release the reaction product IMP.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmb.2007.11.018DOI Listing

Publication Analysis

Top Keywords

human itpase
12
active site
12
interdomain interprotomer
12
nonstandard nucleotide
8
nucleotide triphosphate
8
triphosphate pyrophosphatase
8
pyrococcus horikoshii
8
horikoshii ot3
8
conformational changes
8
crystal structures
8

Similar Publications

Article Synopsis
  • Thiopurine drugs are used to treat conditions like inflammatory bowel disease, and their metabolism is influenced by the enzymes TPMT and ITPA.
  • This study focuses on Tunisian patients to assess how genetic factors and other variables affect the pharmacokinetics of thiopurine drugs.
  • The research found specific genetic variants and identified gender as a significant factor affecting drug variability, emphasizing the importance of TPMT testing for optimal treatment safety and efficacy.
View Article and Find Full Text PDF

Thiopurines, an effective therapy for Crohn's disease (CD), often lead to adverse events (AEs). Gene polymorphisms affecting thiopurine metabolism may predict AEs. This retrospective study in CD patients (n = 114) with TPMT activity > 5 Units/Red Blood Cells analyzed TPMT (c.

View Article and Find Full Text PDF

Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy.

BMC Infect Dis

March 2024

University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Raiwind Road Campus, Lahore, Pakistan.

Background: Globally, 80 million people are suffering from chronic Hepatitis C virus (HCV) infection. Sofosbuvir ribavirin-based anti-HCV therapy is associated with anemia and other adverse effects. Polymorphisms of Inosine triphosphatase (ITPA) gene may cause functional impairment in the Inosine triphosphate pyrophosphatase enzyme, resulting in enhanced sustained viral response (SVR) and protection from ribavirin-associated anemia in patients on therapy.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between genetic variations (specifically, ITPA C94A polymorphism) and adverse effects caused by the immunosuppressant azathioprine (AZA) in patients with immune disorders.
  • A total of 120 patients undergoing AZA therapy were analyzed, involving blood collection and DNA testing to evaluate their genetic makeup.
  • Results indicate no significant correlation between the ITPA polymorphism and the adverse effects of AZA among South Indian patients, suggesting genetic factors may not heavily influence AZA-related side effects in this population.
View Article and Find Full Text PDF

An ITPA Enzyme with Improved Substrate Selectivity.

Protein J

February 2024

Department of Chemistry, Biochemistry & Physics, Eastern Washington University, Cheney, WA, 99004, USA.

Recent clinical data have identified infant patients with lethal ITPA deficiencies. ITPA is known to modulate ITP concentrations in cells and has a critical function in neural development which is not understood. Polymorphism of the ITPA gene affects outcomes for both ribavirin and thiopurine based therapies and nearly one third of the human population is thought to harbor ITPA polymorphism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!